Therapeutic Lipidology
Publication year: 2021
: 978-3-030-56514-5
The chapters focus on recent advances in the field including novel biomarkers and the microbiome, genomics of cardiovascular risks, PCSK9 inhibitors, imaging technologies, and epidemiology of atherosclerotic cardiovascular disease. The book describes new guidelines, novel therapeutic agents, and changes in the understanding of specific lipoproteins and subclasses with regard to their relationships to cardiovascular disease risk. The second edition contains more than thirty chapters covering such topics as the history of lipidology, lipoprotein metabolism and vascular biology, disorders of lipid metabolism, lifestyle/dietary and pharmacologic management for dyslipidemia, the management of dyslipidemia in certain subgroups (e.g., women, children, older patients) and lipid testing, as well as an examination of other biomarkers and testing procedures related to atherosclerosis and cardiovascular disease.
: Medicine, Cardiology, Endocrinology, Pharmacotherapy, Atherosclerosis and lipidology, Cardiometabolic disease and lipidology, Cholesterol management, Clinical lipidology, Diabetes mellitus, Hypercholesterolemia, Imaging and lipidology, Inflammatory disorders and lipidology, Lipid disorders, Lipids and lipoproteins, Lipidology and the micobiome, PCSK9 inhibitors and lipidology
